Concepedia
Statistics
Publications
5
Citations
1.4K
H-Index
Active since
2010
Affiliations
Lancaster University(Current)
University of Edinburgh
Nottingham University Hospitals NHS Trust
University of Manchester
Roslin Institute
Alice Melville is an author at Lancaster University specializing in pharmacotherapy, 28-day mortality, and open-label trials.
Publications per year
2010–2023
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +11
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text
Life Sciences, Immunology, Pharmacotherapy +14
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +13
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2023 · 132 citations · Full text
Medicine, Internal Medicine, Pharmacotherapy +17
COPD prevalence and its association with occupational exposures in a general population
Alice Melville, Tanja Pless‐Mulloli, O.A. Afolabi et al. · European Respiratory Journal · 2010 · 59 citations · Full text
Medicine, Health Sciences, Occupational Health +12
1–5 of 5